Projects per year
Personal profile
Education
- 2004-2016 Ph.D., Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 1999-2001 M.S., School of Medicine, Taipei Medical University
- 1987-1994 M.D., School of Medicine, Taipei Medical College
Experience
- Attending, Department of Pathology, Taipei Municipal Wanfang Hospital
- Director, Department of Pathology, Taipei Municipal Wanfang Hospital
- 2019.08- Associate Professor, Department of Pathology, Taipei Medical University
- 2014.08-2019.07 Assistant Professor, Department of Pathology, School of Medicine, Taipei Medical University
- 2001.08-2014.07 Instructor, Department of Pathology, School of Medicine, Taipei Medical University
- 1996.09-2002.06 Resident Physician, Taipei Medical College Hospital
- 1996.07-1996.08 Resident Physician, Chang Gung Memorial Hospital
Research Interests
- Brain cancer, prostate cancer, cancer of gastrointestinal tract, immunohistochemistry, molecular pathology
Fingerprint
Dive into the research topics where Wei-Yu Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
候選基因在子宮內膜異位、非癌性毛勒氏管組織，子宮內膜癌前病變和子宮內膜癌的表達(I/II)
1/1/21 → 12/31/21
Project: B - Project of TMU › h - Higher Education Sprout Project
-
候選基因在子宮內膜異位、非癌性毛勒氏管組織，子宮內膜癌前病變和子宮內膜癌的表達(I/II)
1/1/20 → 12/1/20
Project: B - Project of TMU › h - Higher Education Sprout Project
-
Targeting a Novel Neurotrophic Signaling Ngf-Chrm4 in Drug-Resistant Neuroendocrine Prostate Cancer
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
-
北醫大的表基因轉譯工作組-檢測人類組織中表基因和表轉錄基因機制
1/1/19 → 12/1/19
Project: A - Government Institution › d - Ministry of Education
-
Targeting the Inflammation as a Novel Therapy for Neuroendocrine Prostate Cancer Determined by Zbtb46
8/1/18 → 7/1/19
Project: A - Government Institution › b - Ministry of Science and Technology
-
Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance
Chen, W. Y., Wen, Y. C., Lin, S. R., Yeh, H. L., Jiang, K. C., Chen, W. H., Lin, Y. S., Zhang, Q., Liew, P. L., Hsiao, M., Huang, J. & Liu, Y. N., Dec 2021, In: Communications Biology. 4, 1, 22.Research output: Contribution to journal › Article › peer-review
Open Access -
Anatomical relationships between medullary veins and three types of deep-seated malignant brain tumors as detected by susceptibility-weighted imaging
Yang, S. H., Hong, C. T., Tsai, F. Y., Chen, W. Y., Chen, C. Y. & Chan, W. P., Jan 1 2020, In: Journal of the Chinese Medical Association : JCMA. 83, 2, p. 164-169 6 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Dishevelled 1-Regulated Superpotent Cancer Stem Cells Mediate Wnt Heterogeneity and Tumor Progression in Hepatocellular Carcinoma
Liao, W. Y., Hsu, C. C., Chan, T. S., Yen, C. J., Chen, W. Y., Pan, H. W. & Tsai, K. K., Mar 10 2020, In: Stem Cell Reports. 14, 3, p. 462-477 16 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus) -
EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer
Lin, S. R., Wen, Y. C., Yeh, H. L., Jiang, K. C., Chen, W. H., Mokgautsi, N., Huang, J., Chen, W. Y. & Liu, Y. N., Oct 29 2020, In: Oncogene. 39, 44, p. 6757-6775 19 p.Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus) -
Granuloma With an Underlying Lymphoma: A Diagnostic Challenge and a Wider Histologic Spectrum Including Adult T-Cell Leukemia/Lymphoma
Wu, C. Y., Wang, R. C., Chen, B. J., Chen, W. Y., Jhuang, J. Y., Chang, M. C., Wu, Y. H., Nakada, N., Karube, K. & Chuang, S. S., Apr 1 2020, In: Applied immunohistochemistry & molecular morphology : AIMM. 28, 4, p. 316-324 9 p.Research output: Contribution to journal › Article › peer-review
5 Citations (Scopus)
Datasets
-
Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
Tsai, Y. (Contributor), Zeng, T. (Contributor), Abou-Kheir, W. (Contributor), Yeh, H. (Contributor), Yin, J. (Contributor), Lee, Y. (Contributor), Chen, W. (Contributor) & Liu, Y. (Contributor), Unknown Publisher, Feb 19 2018
DOI: 10.6084/m9.figshare.c.4008787.v1, https://figshare.com/collections/Disruption_of_ETV6_leads_to_TWIST1-dependent_progression_and_resistance_to_epidermal_growth_factor_receptor_tyrosine_kinase_inhibitors_in_prostate_cancer/4008787/1
Dataset
-
Additional file 1: of Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
Tsai, Y. (Contributor), Zeng, T. (Contributor), Abou-Kheir, W. (Contributor), Yeh, H. (Contributor), Yin, J. (Contributor), Lee, Y. (Contributor), Chen, W. (Contributor) & Liu, Y. (Contributor), Unknown Publisher, Feb 19 2018
DOI: 10.6084/m9.figshare.5900626.v1, https://springernature.figshare.com/articles/Additional_file_1_of_Disruption_of_ETV6_leads_to_TWIST1-dependent_progression_and_resistance_to_epidermal_growth_factor_receptor_tyrosine_kinase_inhibitors_in_prostate_cancer/5900626/1
Dataset